부산대학교 도서관

Swee Y. Sharp; Marianna Martella; Sabrina D’Agostino; Christopher I. Milton; George Ward; Andrew J. Woodhead; Caroline J. Richardson; Maria G. Carr; Elisabetta Chiarparin; Benjamin D. Cons; Joseph Coyle; Charlotte E. East; Steven D. Hiscock; Carlos Martinez-Fleites; Paul N. Mortenson; Nick Palmer; Puja Pathuri; Marissa V. Powers; Susanne M. Saalau; Jeffrey D. St. Denis; Kate Swabey; Mladen Vinković; Hugh Walton; Glyn Williams; Paul A. Clarke

Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)

A. Y. S. Balazs; N. L. Davies; D. Longmire; M. J. Packer; E. Chiarparin

Magnetic Resonance, Vol 2, Pp 489-498 (2021)

Schlagnitweit, J; Sandoz, SF; Jaworski, A; Guzzetti, I; Aussenac, F; Carbajo, RJ; Chiarparin, E; Pell, AJ; Petzold, K

CHEMBIOCHEM. 20(19):2474-2478

Adriana E. Tron; Matthew A. Belmonte; Ammar Adam; Brian M. Aquila; Lawrence H. Boise; Elisabetta Chiarparin; Justin Cidado; Kevin J. Embrey; Eric Gangl; Francis D. Gibbons; Gareth P. Gregory; David Hargreaves; J. Adam Hendricks; Jeffrey W. Johannes; Ricky W. Johnstone; Steven L. Kazmirski; Jason G. Kettle; Michelle L. Lamb; Shannon M. Matulis; Ajay K. Nooka; Martin J. Packer; Bo Peng; Philip B. Rawlins; Daniel W. Robbins; Alwin G. Schuller; Nancy Su; Wenzhan Yang; Qing Ye; Xiaolan Zheng; J. Paul Secrist; Edwin A. Clark; David M. Wilson; Stephen E. Fawell; Alexander W. Hird

Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)

Schlagnitweit, J; Sandoz, SF; Jaworski, A; Guzzetti, I; Aussenac, F; Carbajo, RJ; Chiarparin, E; Pell, AJ; Petzold, K

bioRxiv.

Smith, James M.; Barlaam, Bernard; Beattie, David; Bradshaw, Lauren; Chan, Ho Man; Chiarparin, Elisabetta; Collingwood, Olga; Cooke, Sophie L.; Cronin, Anna; Cumming, Iain; Dean, Emma; Debreczeni, Judit É.; del Barco Barrantes, Iván; Diene, Coura; Gianni, Davide; Guerot, Carine; Guo, Xiaoxiao; Guven, Sinem; Hayhow, Thomas G.; Hong, Ted

Journal of Medicinal Chemistry. 8/22/2024, Vol. 671 Issue 6, p13604-13638. 35p.

Chiarparin, E; Pelupessy, P; Cutting, B; Eykyn, TR; Bodenhausen, G

Journal of Biomolecular NMR. 13:61-65

Hayhow, T.G.; Williamson, B.; Lawson, M.; Cureton, N.; Braybrooke, E.L.; Carbajo, R.J.; Cheraghchi-Bashi, A.; Chiarparin, E.; Diène, C.R.; Fallan, C.; Goldberg, F.W.; Hopcroft, L.; Kettle, J.G.; Klinowska, T.; Lamont, G.; Lewis, H.J.; Maglennon, G.; Martin, S.; Gutierrez, P.M.; Morrow, C.J.; Nikolaou, M.; Nissink, J.W.M.; Schade, M.; Scott, J.S.; Smith, A.; Weber, J.; Wilson, J.; Crafter, C.; Campbell, A.; Fisher, D.I.; Hopcroft, P.; Jackson, A.; Künzel, U.; O’Shea, P.; Polanski, R.; Yang, B.

In: Communications Biology. (Communications Biology, December 2024, 7(1))

Schade M; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Scott JS; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Hayhow TG; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Pike A; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Terstiege I; Chemistry and DMPK, Research and Early Development, Respiratory and Immunology, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal 43183, Sweden.; Ahlqvist M; Chemistry and DMPK, Research and Early Development, Respiratory and Immunology, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal 43183, Sweden.; Johansson JR; Chemistry and DMPK, Research and Early Development, Respiratory and Immunology, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal 43183, Sweden.; Diene CR; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Fallan C; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Balazs AYS; Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Chiarparin E; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.; Wilson D; Chemistry and DMPK, Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Adihou H; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; AstraZeneca-MPI Satellite Unit, Dortmund, Germany.; Gopalakrishnan R; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; AstraZeneca-MPI Satellite Unit, Dortmund, Germany.; Förster T; AstraZeneca-MPI Satellite Unit, Dortmund, Germany.; Guéret SM; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; AstraZeneca-MPI Satellite Unit, Dortmund, Germany.; Gasper R; Max Planck Institute for Molecular Physiology, Dortmund, Germany.; Geschwindner S; Structure & Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Carrillo García C; Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University of Kiel, Kiel, Germany.; Karatas H; Max Planck Institute for Molecular Physiology, Dortmund, Germany.; Pobbati AV; Department of Multi-Modal Molecular (M3) Biology, ASTAR Institute of Molecular and Cell Biology, Singapore, Singapore.; Vazquez-Chantada M; Mechanistic Biology & Profiling, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Davey P; Medicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, UK.; Wassvik CM; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Pang JKS; Disease Modelling and Therapeutics Laboratory, ASTAR Institute of Molecular and Cell Biology, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Soh BS; Disease Modelling and Therapeutics Laboratory, ASTAR Institute of Molecular and Cell Biology, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Hong W; Department of Multi-Modal Molecular (M3) Biology, ASTAR Institute of Molecular and Cell Biology, Singapore, Singapore.; Chiarparin E; Medicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, UK.; Schade D; Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University of Kiel, Kiel, Germany.; Plowright AT; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Valeur E; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Lemurell M; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Grossmann TN; Department of Chemistry and Pharmaceutical Sciences, VU University Amsterdam, Amsterdam, Netherlands. t.n.grossmann@vu.nl.; Amsterdam Institute of Molecular and Life Sciences (AIMMS), VU University Amsterdam, Amsterdam, Netherlands. t.n.grossmann@vu.nl.; Waldmann H; Max Planck Institute for Molecular Physiology, Dortmund, Germany. herbert.waldmann@mpi-dortmund.mpg.de.; Department of Chemistry and Chemical Biology, Technical University Dortmund, Dortmund, Germany. herbert.waldmann@mpi-dortmund.mpg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Atkinson SJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Bagal SK; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Argyrou A; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Askin S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Cheung T; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Chiarparin E; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Coen M; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Collie IT; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dale IL; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; De Fusco C; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dillman K; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Evans L; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Feron LJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Foster AJ; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Grondine M; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Kantae V; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont GM; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont S; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lynch JT; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Nilsson Lill S; Data Sciences & Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.; Robb GR; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Saeh J; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Schimpl M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Scott JS; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Smith J; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Srinivasan B; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Tentarelli S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Vazquez-Chantada M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Wagner D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Walsh JJ; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Watson D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Williamson B; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Cromm PM; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.; Present address: Research and Development, Pharmaceuticals, Bayer AG, Muellerstrasse 178, 13353, Berlin, Germany.; Adihou H; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Early CVRM Medicinal Chemistry, R&D BioPharmaceuticals, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden.; Kapoor S; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Vazquez-Chantada M; Chemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Davey P; Chemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Longmire D; Chemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Hennes E; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Hofer W; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Küchler P; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Chiarparin E; Chemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Waldmann H; Department of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 6, 44227, Dortmund, Germany.; Grossmann TN; Vrije Universiteit Amsterdam, Department of Chemistry and Pharmaceutical Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands.

Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE

Linnane E; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB10 1XL, UK.; Davey P; Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB4 0WG, UK.; Zhang P; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB10 1XL, UK.; Puri S; Advanced Drug Delivery, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, CB21 6GH, UK.; Edbrooke M; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB10 1XL, UK.; Chiarparin E; Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB4 0WG, UK.; Revenko AS; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.; Macleod AR; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.; Norman JC; Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.; Ross SJ; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB10 1XL, UK.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE

Wilsher, N.; Saalau-Bethell, S.; Woodhead, A.; Millemaggi, A.; Graham, B.; Hamlett, C.; Murray, C.; Norton, D.; Rees, D.; Chiarparin, E.; Willems, H.; Lewis, J.; Fazal, L.; Carr, M.; Hodder, M.; Reader, M.; Thompson, N.; Pathuri, P.; Rich, S.; Hiscock, S.; Martins, V.; Sanders, M.

Journal of Hepatology. 56:S342-S342

Dewis LI; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.; Rudrakshula M; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.; Williams C; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.; Chiarparin E; Chemistry, R&D Oncology, AstraZeneca, Cambridge, CB4 0QA, UK.; Myers EL; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.; School of Biological and Chemical Sciences, University of Galway, University Road, Galway, Ireland.; Butts CP; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.; Aggarwal VK; School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.

Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE

Hargreaves D; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Carbajo RJ; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Bodnarchuk MS; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Embrey K; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Rawlins PB; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Packer M; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Degorce SL; Discovery Sciences, AstraZeneca, Waltham, MA 02451.; Hird AW; Discovery Sciences, AstraZeneca, Waltham, MA 02451.; Johannes JW; Discovery Sciences, AstraZeneca, Waltham, MA 02451.; Chiarparin E; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Schade M; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Scott JS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Stead D; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Barlaam B; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Breed J; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Chiarparin E; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Cureton N; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Davey PRJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Fisher DI; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Gangl ET; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Grebe T; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Greenwood RD; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Hande S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Hatoum-Mokdad H; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Hughes SJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Hunt TA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Johnson T; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Kavanagh SL; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB2 OAA, United Kingdom.; Klinowska TCM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Larner CJB; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB2 OAA, United Kingdom.; Lawson M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Lister AS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Longmire D; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Marden S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts 02451, United States.; McGuire TM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; McMillan C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; McMurray L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Morrow CJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Nissink JWM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Moss TA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; O'Donovan DH; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Polanski R; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Stokes S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Thakur K; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Trueman D; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Truman C; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Tucker MJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Wang H; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Whalley N; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Wu D; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts 02451, United States.; Wu Y; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Yang B; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Yang W; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Boston, Massachusetts 02451, United States.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Kapustin AN; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. alexander.kapustin@astrazeneca.com.; Davey P; Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Longmire D; Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Matthews C; Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK.; Linnane E; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Rustogi N; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK.; Stavrou M; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK.; Devine PWA; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK.; Bond NJ; Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Cambridge, UK.; Hanson L; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Alderley Park, UK.; Sonzini S; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Revenko A; Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA.; MacLeod AR; Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA.; Ross S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Chiarparin E; Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Puri S; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

De Fusco C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Börjesson U; Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden.; Cheung T; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Collie I; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Evans L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Narasimhan P; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Stubbs C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Vazquez-Chantada M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Wagner DJ; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Grondine M; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Sanders MG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Tentarelli S; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Underwood E; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Argyrou A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Smith JM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Lynch JT; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Chiarparin E; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Robb G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Scott JS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Bertarello A; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.; Berruyer P; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.; Artelsmair M; Early Chemical Development, Pharmaceutical Science, R&D, AstraZeneca, SE-431 83 Mölndal, Sweden.; Elmore CS; Early Chemical Development, Pharmaceutical Science, R&D, AstraZeneca, SE-431 83 Mölndal, Sweden.; Heydarkhan-Hagvall S; Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, SE-431 83 Mölndal, Sweden.; Schade M; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Chiarparin E; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Schantz S; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, SE-431 83 Mölndal, Sweden.; Emsley L; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 7503056 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5126 (Electronic) Linking ISSN: 00027863 NLM ISO Abbreviation: J Am Chem Soc Subsets: MEDLINE